MC
MannKind Corp
🇺🇸XNAS.MNKDUnited StatesHealthcare
$3.59USDup +0.02 (+0.56%)OpenDelayed3:28 PM
Price$3.59+0.02 (+0.56%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US56400P7069
- CUSIP
- 56400P201
Company
- Employees
- 591
- Headquarters
- Danbury, United States
- Website
- https://mannkindcorp.com
- CEO
- Dr. Michael E. Castagna Pharm.D.
Market
- Shares outstanding
- 321.5M
- Market cap
- $1.15B
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- $1.15B
- EPS LTM
- -$0.14
- P/E LTM
- -30.48
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $393.63M+30.46%up year on year
- Net income
- -$43.61M-232.98%down year on year
- Gross margin
- 75.69%+1.04%up year on year
- Free cash flow
- -$18.57M-164.5%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.